Actively Recruiting
Creation of a Biological Collection to Study the Pathophysiology and Identify Predictive Factors for the Evolution of Bone, Calcium and Growth Plate Pathologies
Led by University Hospital, Toulouse · Updated on 2026-06-05
350
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are collecting biological and clinical data from patients with progressive bone, calcium, and growth plate diseases. The goal is to better understand the biological processes behind these conditions and to identify factors that predict disease progression and potential new treatment targets. This observational study is sponsored by University Hospital, Toulouse, and focuses on patients of all ages up to 99 years old with these pathologies. Participants will undergo regular clinical monitoring, including blood and urine tests. In cases where surgery is part of the treatment, surgical residues may also be collected and preserved. These biological samples and clinical data will be gathered over an average period of 5 years to build a comprehensive collection for ongoing research. Throughout the study, patients will have clinical and biological evaluations to provide data for research. The main measure is the building of this biological and clinical collection from day 0 through study completion. Researchers will also look for markers that may indicate disease progression based on new insights gained from the data. Participants will be monitored regularly as part of their routine care, and the study may last up to 5 years or more.
CONDITIONS
Brief Title
Clinico-biological Collection of Bone, Calcium and Growth Plate Pathologies
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children (from birth) with growth plate or bone pathology
- Patients affiliated to or benefiting from a social security scheme
- Patients able to receive information about the study and to understand the information form in order to participate in the study, including mastery of the French language
- Not being subject to a restriction of rights by the judicial authorities
- Patients or legal representatives having given their consent to participate in the study (expression of non-opposition)
You will not qualify if you...
- Patients under legal protection (guardianship, curatorship or safeguard of justice)
- Pregnant or breast-feeding women
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - An average of 5 years
Participants who have growth plate or bone pathology are observed through clinical monitoring and regular blood and urine tests.
Regular blood and urine tests as part of clinical monitoring
Trial Site Locations
Total: 1 location
1
University Toulouse Hospital
Toulouse, France, 31000
Actively Recruiting
Research Team
T
Thomas EDOUARD, MD
S
Sanaa EDDIRY
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here